Table 3: (a) TB treatment outcomes according to baseline CD4 category in patients initiating ART following TB treatment in the Kericho District Hospital Integrated TB/HIV clinic ( ). (b) TB treatment outcomes according to time of ART initiation in patients in the Kericho District Hospital Integrated TB/HIV Clinic ( ).
(a)

CD4 distributions (cells/mm3)TB treatment outcomeRow totals
Treatment successTransferred outLost to followupDied

<50116 (66.3)18 (10.3)22 (12.8)19 (10.7)175 (28.6)
50–99101 (68.7)21 (14.3)16 (10.9)9 (6.1)147 (24.0)
100–199163 (77.3)18 (8.5)27 (12.8)3 (1.4)211 (34.5)
200–34953 (86.9)4 (6.6)3 (4.9)1 (3.1)61 (10.0)
≥35016 (88.9)1 (5.6)1 (5.6)0 (0)18 (2.9)

Notes:
(1) Data presented as number (percentage for row total). Data missing: 10.5% for combination of CD4 distributions and TB treatment outcome.
(2) Treatment Success defined as cure or treatment complete.
(b)

Time of ARTTb Treatment OutcomeRow totals
Treatment successTransferred outLost to followupDied

ART Prior to TB Treatment122 (75.3)12 (7.4)14 (8.6)14 (8.6)162 (20.5)
ART Following TB Treatment
 <2 weeks39 (65.0)5 (8.3)10 (16.7)6 (10.0)60 (7.6)
 2 weeks–<2 months227 (66.8)50 (14.7)45 (13.2)18 (5.3)340 (43.0)
 2–6 months143 (81.7)7 (4.0)15 (8.6)10 (5.7)175 (22.2)
 >6 months49 (92.5)1 (1.6)2 (3.8)1 (1.9)53 (6.7)

Notes:
(1) Data presented as number (percentage of row total). Data missing: 10.1% for combination of time of ART and TB treatment outcome.
(2) Treatment success defined as cure or treatment complete.